Aurora Biliary Stent System
510(k) K030839
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESU | NumberK030839 | Date30 May 2003 | StatusActive |
Recalls
No FDA recalls found in the data synced 22 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- Full name
- Medtronic Ave Bridge Aurora Biliary Stent System (Aurora)
- 510(k) Number
- FDA Product Code
- FGE
- Device Class
- Class II
- Regulation
- 21 CFR Part 876.5010
- Advisory Committee
- Gastroenterology, Urology
- FDA Decision
- SESU
Overview
AI-generated summary, 20 Sep 2026
The Aurora Biliary Stent System is a self-expanding, tubular nitinol stent designed for biliary duct drainage. It is classified as a stent, drain, and dilator for the biliary ducts and is intended to palliate obstructions caused by malignant neoplasms within the biliary tree. The device features radiopaque markers for fluoroscopic guidance during placement.
This system is delivered transhepatically via a sheathed delivery catheter and is intended for single-use. It is constructed from biocompatible materials and is regulated under FDA 510(k) clearance (K030839) as a Class II device (regulation number 876.5010). The stent is supplied sterile and is intended for use in clinical settings such as endoscopy or interventional radiology.
Other devices from Medtronic Ave, Inc.
Questions
AI-generated answers, 20 Sep 2026
What clinical scenarios is the Aurora Biliary Stent System intended to address specifically within biliary drainage procedures?
The Aurora Biliary Stent System is designed to palliate obstructions caused by malignant neoplasms (cancers) within the biliary tree, which are the ducts responsible for transporting bile from the liver to the small intestine. It is intended for biliary duct drainage to relieve blockages that can lead to conditions like cholestasis or jaundice in patients with malignant biliary strictures.
How is the Aurora Biliary Stent System delivered, and what type of procedural setting is it intended for?
The Aurora Biliary Stent System is delivered transhepatically via a sheathed delivery catheter, meaning it is inserted through the liver into the biliary ducts. It is intended for use in clinical settings such as endoscopy or interventional radiology, where fluoroscopic guidance is available to assist with precise placement.
Is the Aurora Biliary Stent System reusable, or is it intended for single-use only?
The Aurora Biliary Stent System is explicitly intended for single-use only, as stated in its design and regulatory documentation. This ensures patient safety and sterility, as it is supplied sterile and not meant to be reused.
What materials is the Aurora Biliary Stent System constructed from, and why does this matter?
The Aurora Biliary Stent System is constructed from biocompatible materials, which means they are designed to be safe for use within the human body without causing adverse reactions. This is particularly important for long-term drainage applications, as biocompatibility reduces the risk of inflammation, infection, or other complications.
What regulatory pathway was followed for the Aurora Biliary Stent System, and what does this mean for its use?
The Aurora Biliary Stent System was cleared through the FDA’s 510(k) pathway, specifically under clearance number K030839, and is classified as a Class II device under regulation number 876.5010. This means it has undergone a premarket submission process to demonstrate substantial equivalence to a legally marketed predicate device, ensuring it meets FDA safety and effectiveness standards for its intended use in biliary drainage.